Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.8 |